SageView Advisory Group LLC bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,847 shares of the medical device company’s stock, valued at approximately $344,000. Several other […]
Pine Valley Investments Ltd Liability Co bought a new position in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 2,179 shares of the medical device company’s stock, valued at approximately $270,000. A number of other hedge funds and other institutional […]
Freemont Management S.A. cut its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 55.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,000 shares of the medical device company’s stock after selling 124,200 shares during the period. DexCom accounts […]
Freemont Management S.A. lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 55.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 100,000 shares of the medical device company’s stock after selling 124,200 shares during the period. DexCom makes up approximately 1.6% of […]
DexCom (NASDAQ:DXCM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Several other brokerages have also recently commented on DXCM. Royal Bank of Canada initiated coverage on shares of DexCom in a research note on Tuesday, March […]